0001437749-23-021073.txt : 20230728
0001437749-23-021073.hdr.sgml : 20230728
20230728180609
ACCESSION NUMBER: 0001437749-23-021073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230726
FILED AS OF DATE: 20230728
DATE AS OF CHANGE: 20230728
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Fred E
CENTRAL INDEX KEY: 0001339358
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 231124507
MAIL ADDRESS:
STREET 1: 301 COMMERCE STREET
STREET 2: SUITE 3300
CITY: FORT WORTH
STATE: TX
ZIP: 76102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-07-26
0001668243
UroGen Pharma Ltd.
URGN
0001339358
Cohen Fred E
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
0
Ordinary Shares
2023-07-26
4
A
0
69339
9.54
A
69339
I
by Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer
Represents the reporting person's proportionate interest in shares acquired by entities affiliated with Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer
/s/ Jason Smith, Attorney-in-Fact
2023-07-28